| 标题 |
[求助补充材料]
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Bruno Sangro; Masatoshi Kudo; Joseph P. Erinjeri; Shukui Qin; Zhenggang Ren; et al 出版日期:2025-01-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)